From trying to create new cartilage in the laboratory to clinical trials for patients with brain injuries, scientists and physicians at The University of Texas Health Science Center at Houston (UTHealth) are leading the way in stem cell research.
In partnership with Memorial Hermann-Texas Medical Center, UTHealth was the first in the country to intravenously inject a stroke patient’s own stem cells in a trial funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Learn how researchers continue to push the boundaries of this promising field.
UTHealth research: Stem cell therapy appears to have TBI treatment effect
Results of a cellular therapy clinical trial for traumatic brain injury (TBI) using a patient’s own stem cells showed that the therapy appears to dampen the body’s neuroinflammatory response to trauma and preserve brain tissue, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).Continue reading »
UTHealth receives $6.8 million from DOD to study stem cell therapy for TBI
A research team led by Charles S. Cox, Jr., M.D., at The University of Texas Health Science Center at Houston (UTHealth) has been awarded $6.8 million from the U.S. Department of Defense (DOD) to assess the safety and efficacy of using autologous stem cell therapy in adults with emergent traumatic brain injury.Continue reading »
Scientists discover on/off switch for obesity-associated cancer
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) is furthering the understanding of the link between obesity and cancer.Continue reading »